No Exercise Boost From Pacemaker in HFpEF With Impaired HR
The findings challenge pacing recommendations in HFpEF with chronotropic incompetence and should highlight the disorder's systemic nature, say observers.
Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The findings challenge pacing recommendations in HFpEF with chronotropic incompetence and should highlight the disorder's systemic nature, say observers.
In a recent study published in JAMA, researchers investigated whether treat-to-target (TTT) low-density lipoprotein-cholesterol (LDL-C) therapy was inferior to administering statins of high intensity for clinical outcomes in the long term among coronary artery disease (CAD) patients.
Researchers examine the impact of an exclusive human milk diet on the infant gut microbiome.
Optune is now available as a treatment for newly diagnosed glioblastoma patients in France Novocure (NASDAQ:NVCR) today announced the reimbursement and availability of Optune together with temozolomide
Looking for the best joint supplements in 2023? Check out our picks for the top 6 joint health products on the market this year.